Roche Vs. Pfizer: Obesity Week Presentations Deep Dive - What Investors Must Know
Source: SeekingAlpha
2026-06-10 13:44:23 ET
Investment Overview: Why Roche & Pfizer Are Pinning Hopes On Obesity / Type 2 Diabetes Assets
Read the full article on Seeking Alpha
For further details see:
Roche Vs. Pfizer: Obesity Week Presentations Deep Dive - What Investors Must Know
Novo Nordisk - Class B
NASDAQ: NONOF
NONOF Trading
-1.76% G/L:
$49.85 Last:
6,030 Volume:
$51.23 Open:
NONOF Latest News
$217,715,792,624
1,607,906,287
N/A
1546
N/A
Biotechnology & Life Sciences
Healthcare
DK
Bagsvaerd
